ARCHIVES

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

This article is from The Cancer Letter archive.

Vol. 23 No. 25 | June 27, 1997

Download PDF Visit The Full Archive

Related Articles

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

November 19, 2004

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002